Bare Metal Stents Market Size - By Product (Self-expandable, Balloon Expandable), Material Type (Stainless Steel, Cobalt-Chromium Alloy, Nitinol), Application (Coronary, Peripheral), End-use (Hospitals, ASCs) & Forecast, 2023

Description

List of Tables

Global Bare Metal Stents Market will witness 2.8% CAGR between 2023 and 2032, driven by extensive research endeavors aimed at comprehending and appraising these devices, spearheaded by top researchers. As studies deepen the understanding of bare metal stents' efficacy and limitations, this market witnesses a surge.

For instance, in June 2023, W. L. Gore & Associates (Gore) initiated the Gore VBX FORWARD Clinical Study to evaluate the effectiveness of the VBX Stent Graft compared to bare metal stenting in treating complex iliac occlusive disease. The relentless pursuit of insights into their performance, durability, and compatibility fuels this demand. As leading researchers delve deeper into optimizing design and material compositions, their findings propel the bare metal stents market demand, shaping the evolution and applications of bare metal stents in modern medical practices.

The overall Bare Metal Stents Industry is classified based on product, application, and region.

Self-expandable stent segment will undergo significant development from 2023 to 2032. These advanced stents offer versatility and adaptability, catering to intricate anatomical structures. With their self-expanding capability, these stents provide precise deployment and secure vessel support. As medical practitioners seek efficient and minimally invasive solutions, the demand for self-expanding bare metal stents skyrockets. Their ability to conform to diverse vessel sizes and complexities marks a pivotal shift, propelling the bare metal stents market growth trajectory in the pursuit of improved patient outcomes and enhanced procedural efficacy.

Peripheral artery segment will register a noteworthy CAGR from 2023 to 2032. With peripheral artery diseases on the rise, bare metal stents serve as vital tools in restoring blood flow and providing structural support. As medical interventions prioritize minimally invasive procedures, the demand for these stents escalates. Their ability to reinforce narrowed arteries and maintain vessel patency addresses critical needs in peripheral artery interventions, reflecting the bare metal stents market expansion from reliable and efficient treatment options.

Asia Pacific bare metal stents market will showcase a commendable CAGR from 2023 to 2032. With a burgeoning population and increased prevalence of cardiovascular diseases, there's a pressing need for effective treatment solutions.

Bare metal stents play a pivotal role in this scenario, offering cost-effective and reliable options for artery disease management. As the region focuses on advanced medical interventions, the demand for these stents soars, reflecting their crucial role in addressing cardiovascular health challenges across Asia Pacific. For instance, in April 2023, in India, the price caps on coronary stents, covering both bare metal and drug-eluting variants, were raised following the Wholesale Price Index (WPI) revision. As per the directive from the National Pharmaceutical Pricing Authority (NPPA), the maximum price for bare metal stents was adjusted to Rs 10,509.

Product Code: 6844

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.4 Data collection
1.5 Forecast parameters
1.6 COVID-19 impact at global level
1.7 Data validation
1.8 Data sources
- 1.8.1 Primary
- 1.8.2 Secondary
  - 1.8.2.1 Paid sources
  - 1.8.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Bare metal stents industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Material type trends
- 2.1.5 Application trends
- 2.1.6 End-use trends

Chapter 3 Bare Metal Stents Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of cardiovascular diseases
  - 3.2.1.2 Growing geriatric population
  - 3.2.1.3 Rising advancements in the design and materials
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Higher risk of stent thrombosis
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By material type
- 3.3.3 By application
- 3.3.4 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Pricing analysis, 2022
3.7 Reimbursement scenario
3.8 Future market trends
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022

Chapter 5 Bare Metal Stents Market Size and Forecast, By Product (USD Million)

5.1 Key trends, by product
5.2 Self-expandable stent
5.3 Balloon expandable stent

Chapter 6 Bare Metal Stents Market Size and Forecast, By Material Type (USD Million)

6.1 Key trends, by material type
6.2 Stainless steel stents
6.3 Cobalt-chromium alloy stents
6.4 Nitinol

Chapter 7 Bare Metal Stents Market Size and Forecast, By Application (USD Million)

7.1 Key trends, by application
7.2 Coronary artery disease
7.3 Peripheral artery disease
7.4 Others

Chapter 8 Bare Metal Stents Market Size and Forecast, By End-use (USD Million)

8.1 Key trends, by end-use
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Others

Chapter 9 Bare Metal Stents Market Size and Forecast, By Region (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of APAC
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of LATAM
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of MEA

Chapter 10 Company Profiles

10.1 Abbott Laboratories
10.2 B. Braun Melsungen AG
10.3 Biosensors International Group
10.4 Sahajanand Laser Technology Limited
10.5 Andramed GmbH
10.6 Meril Life Science
10.7 GENOSS Co., Ltd.
10.8 Boston Scientific Corporation
10.9 Cook Medical
10.10 Medtronic Plc.